Thursday April 5, 5:00 pm Eastern Time
Press Release
SOURCE: Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals Adopts Shareholder
Rights Plan
CAMBRIDGE, Mass., April 5 /PRNewswire/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM - news) announced
today that it has adopted a shareholder rights plan designed to ensure that all Millennium shareholders will receive fair and equal
treatment in the event of any unsolicited attempt to acquire the Company. The plan was not adopted in response to any
unsolicited offer or takeover attempt.
(Photo: newscom.com )
A complete copy of the shareholder rights plan is included in a Current Report on Form 8-K that Millennium filed today with
the SEC. In addition, Millennium stockholders of record on April 16, 2001 will be mailed a detailed summary of the rights.
Millennium, a leading biopharmaceutical company, applies its comprehensive and integrated science and technology platform
for the discovery and development of breakthrough therapeutic and predictive medicine products, with a goal of delivering
personalized medicine. Through the industrialization of this gene-to-patient platform, Millennium is also striving to accelerate the
process of drug discovery and development. Headquartered in Cambridge, Massachusetts, Millennium currently employs more
than 1,300 people.
Editor's Note: This release is available on Millennium's website at www.millennium.com
SOURCE: Millennium Pharmaceuticals, Inc. |
